Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance.

Kalaszczynska I, Ferdyn K.

Biomed Res Int. 2015;2015:430847. doi: 10.1155/2015/430847. Epub 2015 Mar 15. Review.

2.

Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.

Reppel L, Margossian T, Yaghi L, Moreau P, Mercier N, Leger L, Hupont S, Stoltz JF, Bensoussan D, Huselstein C.

Curr Stem Cell Res Ther. 2014;9(4):306-18.

PMID:
24524785
3.

Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications.

Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV.

Int J Mol Sci. 2013 May 31;14(6):11692-712. doi: 10.3390/ijms140611692. Review.

4.

New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.

Anzalone R, Lo Iacono M, Corrao S, Magno F, Loria T, Cappello F, Zummo G, Farina F, La Rocca G.

Stem Cells Dev. 2010 Apr;19(4):423-38. doi: 10.1089/scd.2009.0299. Review.

PMID:
19958166
5.

Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.

Reppel L, Schiavi J, Charif N, Leger L, Yu H, Pinzano A, Henrionnet C, Stoltz JF, Bensoussan D, Huselstein C.

Stem Cell Res Ther. 2015 Dec 30;6:260. doi: 10.1186/s13287-015-0263-2.

6.

Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.

Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A.

Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10. Review.

PMID:
26482184
7.

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly.

Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R.

Stem Cell Res Ther. 2014 Apr 16;5(2):53. doi: 10.1186/scrt442.

8.

Wharton's Jelly stem cells: future clinical applications.

Taghizadeh RR, Cetrulo KJ, Cetrulo CL.

Placenta. 2011 Oct;32 Suppl 4:S311-5. doi: 10.1016/j.placenta.2011.06.010. Epub 2011 Jul 6. Review.

PMID:
21733573
9.

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C.

Curr Stem Cell Res Ther. 2013 Mar;8(2):144-55. Review.

PMID:
23279098
10.

Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.

Hendijani F, Sadeghi-Aliabadi H, Haghjooy Javanmard S.

Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1. Epub 2014 Feb 17.

PMID:
24532125
11.

Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.

Hendijani F, Javanmard SH, Sadeghi-aliabadi H.

Tissue Cell. 2015 Jun;47(3):229-34. doi: 10.1016/j.tice.2015.01.005. Epub 2015 Jan 31.

PMID:
25779671
12.

Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R.

BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18.

13.

Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.

Cell Tissue Res. 2011 Oct;346(1):53-64. doi: 10.1007/s00441-011-1249-8. Epub 2011 Oct 11.

PMID:
21987220
14.

Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.

Zhang L, Zhao YH, Guan Z, Ye JS, de Isla N, Stoltz JF.

Biomed Mater Eng. 2015;25(1 Suppl):137-43. doi: 10.3233/BME-141232. Review.

PMID:
25538064
15.

Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.

Donders R, Vanheusden M, Bogie JF, Ravanidis S, Thewissen K, Stinissen P, Gyselaers W, Hendriks JJ, Hellings N.

Cell Transplant. 2015;24(10):2077-98. doi: 10.3727/096368914X685104. Epub 2014 Oct 10.

PMID:
25310756
16.

Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest.

Ragni E, ViganĂ² M, Parazzi V, Montemurro T, Montelatici E, Lavazza C, Budelli S, Vecchini A, Rebulla P, Giordano R, Lazzari L.

Int J Biochem Cell Biol. 2013 Nov;45(11):2456-66. doi: 10.1016/j.biocel.2013.07.024. Epub 2013 Aug 11.

PMID:
23942228
17.

Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.

Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A, Issaragrisil S.

Intern Med J. 2013 Apr;43(4):430-9. doi: 10.1111/imj.12044.

PMID:
23176558
18.

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.

Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y.

Int J Mol Med. 2014 Sep;34(3):695-704. doi: 10.3892/ijmm.2014.1821. Epub 2014 Jun 25.

19.

Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.

Richardson SM, Kalamegam G, Pushparaj PN, Matta C, Memic A, Khademhosseini A, Mobasheri R, Poletti FL, Hoyland JA, Mobasheri A.

Methods. 2016 Apr 15;99:69-80. doi: 10.1016/j.ymeth.2015.09.015. Epub 2015 Sep 15. Review.

20.

Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z.

Hum Vaccin Immunother. 2016;12(1):85-96. doi: 10.1080/21645515.2015.1030549.

Supplemental Content

Support Center